Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer

Summary

This phase I trial is studying the side effects and best dose of decitabine and valproic acid in treating patients with non-small cell lung cancer. Drugs used in chemotherapy, such as decitabine and valproic acid, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Timeline

Start

2004-04

Primary completion

2013-02

Completion

—

Drugs

Indications